Compared to Estimates, Douglas Emmett (DEI) Q4 Earnings: A Look at Key Metrics

11.02.26 01:00 Uhr

Werte in diesem Artikel
Aktien

10,44 EUR 0,06 EUR 0,58%

8,50 EUR 0,05 EUR 0,59%

Indizes

16.854,2 PKT -144,8 PKT -0,85%

16.784,9 PKT -236,5 PKT -1,39%

7.071,5 PKT -99,7 PKT -1,39%

For the quarter ended December 2025, Douglas Emmett (DEI) reported revenue of $249.43 million, up 1.8% over the same period last year. EPS came in at $0.35, compared to -$0.01 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $255.12 million, representing a surprise of -2.23%. The company has not delivered EPS surprise, with the consensus EPS estimate being $0.35.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Douglas Emmett performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenues- Total multifamily revenues: $49.88 million versus the two-analyst average estimate of $50.22 million. The reported number represents a year-over-year change of +3%.Revenues- Total office revenues: $199.55 million versus the two-analyst average estimate of $204.91 million. The reported number represents a year-over-year change of +1.5%.Net Earnings Per Share (Diluted): $-0.04 compared to the $-0.05 average estimate based on two analysts.View all Key Company Metrics for Douglas Emmett here>>>Shares of Douglas Emmett have returned -5% over the past month versus the Zacks S&P 500 composite's no change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Just Released: Zacks Top 10 Stocks for 2026Hurry – you can still get in early on our 10 top tickers for 2026. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful.From inception in 2012 through November, 2025, the Zacks Top 10 Stocks gained +2,530.8%, more than QUADRUPLING the S&P 500’s +570.3%.Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2026. You can still be among the first to see these just-released stocks with enormous potential.See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Douglas Emmett, Inc. (DEI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Douglas

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Douglas

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Douglas AG

Wer­bung

Analysen zu Douglas AG

DatumRatingAnalyst
19.02.2026Douglas NeutralUBS AG
11.02.2026Douglas NeutralUBS AG
11.02.2026Douglas BuyDeutsche Bank AG
20.01.2026Douglas BuyDeutsche Bank AG
20.01.2026Douglas NeutralGoldman Sachs Group Inc.
DatumRatingAnalyst
11.02.2026Douglas BuyDeutsche Bank AG
20.01.2026Douglas BuyDeutsche Bank AG
19.01.2026Douglas BuyDeutsche Bank AG
19.01.2026Douglas BuyJefferies & Company Inc.
13.01.2026Douglas BuyJefferies & Company Inc.
DatumRatingAnalyst
19.02.2026Douglas NeutralUBS AG
11.02.2026Douglas NeutralUBS AG
20.01.2026Douglas NeutralGoldman Sachs Group Inc.
20.01.2026Douglas NeutralUBS AG
19.12.2025Douglas NeutralUBS AG
DatumRatingAnalyst
29.01.2013DOUGLAS verkaufenIndependent Research GmbH
05.12.2012DOUGLAS verkaufenFrankfurter Tagesdienst
04.12.2012DOUGLAS verkaufenNational-Bank AG
19.11.2012DOUGLAS reduceCommerzbank Corp. & Markets
16.10.2012DOUGLAS underperformCheuvreux SA

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Douglas AG nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen